We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.77B
AUM Growth
+$282M
Cap. Flow
+$179M
Cap. Flow %
10.07%
Top 10 Hldgs %
30.07%
Holding
2,442
New
714
Increased
405
Reduced
476
Closed
723

Sector Composition

Rank Sector Weight
1 Technology 7.8%
2 Healthcare 6.74%
3 Communication Services 5.4%
4 Consumer Discretionary 5.34%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
451
CME Group
CME
$94.8B
$593K 0.03%
3,602
+3,104
+623% +$549K
NVO
452
Novo Nordisk
NVO
$209B
$593K 0.03%
+22,660
New +$557K
CDNA icon
453
CareDx
CDNA
$2.44B
$590K 0.03%
18,707
+11,037
+144% +$322K
WLL
454
DELISTED
Whiting Petroleum Corporation
WLL
$588K 0.03%
300
+29
+11% +$58.4K
CLR
455
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$584K 0.03%
13,050
-9,026
-41% -$404K
WEN icon
456
Wendy's
WEN
$1.39B
$579K 0.03%
32,385
-63,524
-66% -$1.08M
MGA icon
457
PUT
Magna International
MGA
$18.7B
$575K 0.03%
+11,800
New +$595K
NTES icon
458
NetEase
NTES
$85.4B
$574K 0.03%
+11,880
New +$565K
TKR icon
459
Timken Company
TKR
$8.77B
$573K 0.03%
13,135
-11,333
-46% -$482K
TTWO icon
460
Take-Two Interactive
TTWO
$47.4B
$571K 0.03%
6,046
-3,561
-37% -$345K
TLRA
461
DELISTED
Telaria, Inc.
TLRA
$565K 0.03%
89,074
-117,154
-57% -$489K
CNR
462
DELISTED
Cornerstone Building Brands, Inc.
CNR
$564K 0.03%
91,515
+47,500
+108% +$349K
GMED icon
463
Globus Medical
GMED
$11.6B
$561K 0.03%
11,348
+2,937
+35% +$133K
TT icon
464
CALL
Trane Technologies
TT
$105B
$561K 0.03%
5,200
-800
-13% -$81.1K
AMD icon
465
Advanced Micro Devices
AMD
$767B
$560K 0.03%
+21,936
New +$498K
MTOR
466
DELISTED
MERITOR, Inc.
MTOR
$560K 0.03%
27,516
-3,738
-12% -$76.1K
ECOM
467
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$558K 0.03%
45,778
-11,424
-20% -$136K
VKTX icon
468
Viking Therapeutics
VKTX
$4.02B
$556K 0.03%
55,906
+24,872
+80% +$208K
THC icon
469
Tenet Healthcare
THC
$20.9B
$554K 0.03%
19,194
GBT
470
DELISTED
Global Blood Therapeutics, Inc.
GBT
$553K 0.03%
+10,448
New +$513K
S
471
PUT
DELISTED
Sprint Corporation
S
$553K 0.03%
+97,800
New +$606K
IWO icon
472
PUT
iShares Russell 2000 Growth ETF
IWO
$14.9B
$551K 0.03%
+2,800
New +$533K
TREX icon
473
Trex
TREX
$4.91B
$551K 0.03%
17,900
-9,002
-33% -$315K
META icon
474
CALL
Meta Platforms (Facebook)
META
$1.52T
$550K 0.03%
3,300
-10,400
-76% -$1.65M
CSOD
475
CALL
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$548K 0.03%
+10,000
New +$553K

Similar funds

Prelude Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Prelude Capital Management held 2,442 positions worth $1.77B, up 19% from $1.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $179M of net new capital in Q1 2019, opening 714 new positions and adding to 405 existing holdings. Its largest new stake was Ultimate Software Group Inc: 57,473 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Integrated Device Technology I, an estimated $12.7M trimmed.

  • Prelude Capital Management's largest Q1 2019 buy was Ultimate Software Group Inc: 57,473 shares worth $19M.
  • Prelude Capital Management added most to Celgene Corp in Q1 2019, an estimated $43.9M increase.
  • Prelude Capital Management's biggest Q1 2019 reduction was Integrated Device Technology I, cutting an estimated $12.7M.
  • Prelude Capital Management fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $47.3M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $1.77B portfolio in Q1 2019.
  • Prelude Capital Management opened 714 new positions and closed 723 in Q1 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $1.77B.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.